Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Cardiology
•
Preventive Cardiology
•
Preventive Medicine
•
Geriatric Medicine
•
General Primary Care
For patients over 70 with elevated ASCVD risk but no prior cardiovascular events, do you ever recommend continuing or initiating low-dose aspirin?
Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication
Answer from: at Community Practice
Yes, I might still recommend low-dose ASA for primary prevention for someone over 70 if the patient is very functional.
Sign In
or
Register
to read more
30557
Related Questions
How do you counsel patients with metabolic syndrome who decline statin therapy and have low coronary calcium scores regarding their long-term CVD risk?
In what clinical context(s) do you find Lipoprotein (a) helpful in changing your management?
How do you integrate HIV (+) serostatus into a patient's ASCVD if they would not otherwise qualify for a statin either for primary or secondary prophylaxis?
What is your systolic blood pressure target for patients over 80 with frailty and multiple comorbidities?
What is your general approach for investigation / workup of adults with unintentional weight loss?
How do you consider and approach transition to hospice in a patient with HFrEF who does not appear to tolerate GDMT?
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
What are some practical ways to incorporate cardiac POCUS in the primary care setting?
What is your risk/benefit analysis when deciding on the appropriateness and timing for discontinuation of systemic anticoagulation in patients who underwent ablation for paroxysmal atrial fibrillation with CHADS2VASc score >2?
How do you approach balancing the treatment of urinary incontinence with anticholinergic medications with the use of cholinesterase inhibitors in dementia?